Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous Gout

计划入组 2 人 · 首次发布于 2023 年 12 月 29 日

Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat

计划入组 330 人 · 首次发布于 2012 年 1 月 16 日

Evolution of Tophus and Erosions of Hands and Feet at DECT

计划入组 50 人 · 首次发布于 2019 年 5 月 29 日

Probenecid

C₁₃H₁₉NO₄S · Rx

SNIPR-Gout

URAT1 inhibitors (gout)

Scilex Holding

United States

PEGBIO CO-B

GOVT STANLEY MEDICAL COLLEGE

India

FDA Grants Fast Track Designation to Arthrosi's AR882 for Tophaceous Gout

Arthrosi Therapeutics Achieves Rapid Enrollment Milestone in Phase 3 Gout Trial for Pozdeutinurad

Arthrosi Therapeutics Completes Enrollment in Phase 3 Trial of AR882 for Gout